The pathways regulated by TCPTP and PTP1B are independent of those already proven beneficial in cancer immunotherapy such as PD-1/PDL-1 or CTLA4, whose inhibitory signals are mediated by the phosphatases SHP-1 and SHP-2 (23). The gene discussed is PTPN1; the disease is cancer.